top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Advanced bioelectronic materials / / edited by Ashutosh Tiwari, Hirak K. Patra and Anthony P. F. Turner
Advanced bioelectronic materials / / edited by Ashutosh Tiwari, Hirak K. Patra and Anthony P. F. Turner
Pubbl/distr/stampa Hoboken, New Jersey : , : Scrivener Publishing, , 2015
Descrizione fisica 1 online resource (499 pages) : illustrations (some color)
Disciplina 610.28/4
Collana Advanced Material Series
Soggetto topico Biosensors
Biomedical materials
Electronics in biology
ISBN 1-118-99887-1
1-118-99886-3
1-118-99884-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910208950303321
Hoboken, New Jersey : , : Scrivener Publishing, , 2015
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Advanced bioelectronic materials / / edited by Ashutosh Tiwari, Hirak K. Patra and Anthony P. F. Turner
Advanced bioelectronic materials / / edited by Ashutosh Tiwari, Hirak K. Patra and Anthony P. F. Turner
Pubbl/distr/stampa Hoboken, New Jersey : , : Scrivener Publishing, , 2015
Descrizione fisica 1 online resource (499 pages) : illustrations (some color)
Disciplina 610.28/4
Collana Advanced Material Series
Soggetto topico Biosensors
Biomedical materials
Electronics in biology
ISBN 1-118-99887-1
1-118-99886-3
1-118-99884-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910823568203321
Hoboken, New Jersey : , : Scrivener Publishing, , 2015
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Advanced materials interfaces / / edited by Ashutosh Tiwari, Hirak K. Patra and Xuemei Wang
Advanced materials interfaces / / edited by Ashutosh Tiwari, Hirak K. Patra and Xuemei Wang
Pubbl/distr/stampa Hoboken, New Jersey ; ; Salem, Massachusetts : , : John Wiley & Sons, Inc. : , : Scrivener Publishing, , 2016
Descrizione fisica 1 online resource (526 p.)
Disciplina 530.4/17
Collana Advanced Material Series
Soggetto topico Solid-liquid interfaces
Macromolecules
Supramolecular chemistry
ISBN 1-119-24274-6
1-119-24275-4
1-119-24260-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910135034103321
Hoboken, New Jersey ; ; Salem, Massachusetts : , : John Wiley & Sons, Inc. : , : Scrivener Publishing, , 2016
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Advanced materials interfaces / / edited by Ashutosh Tiwari, Hirak K. Patra and Xuemei Wang
Advanced materials interfaces / / edited by Ashutosh Tiwari, Hirak K. Patra and Xuemei Wang
Pubbl/distr/stampa Hoboken, New Jersey ; ; Salem, Massachusetts : , : John Wiley & Sons, Inc. : , : Scrivener Publishing, , 2016
Descrizione fisica 1 online resource (526 p.)
Disciplina 530.4/17
Collana Advanced Material Series
Soggetto topico Solid-liquid interfaces
Macromolecules
Supramolecular chemistry
ISBN 1-119-24274-6
1-119-24275-4
1-119-24260-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910818068703321
Hoboken, New Jersey ; ; Salem, Massachusetts : , : John Wiley & Sons, Inc. : , : Scrivener Publishing, , 2016
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Advanced theranostic materials / / edited by Ashutosh Tiwari, Hirak K. Patra and Jeong-Woo Choi
Advanced theranostic materials / / edited by Ashutosh Tiwari, Hirak K. Patra and Jeong-Woo Choi
Pubbl/distr/stampa Salem, Massachusetts : , : Scrivener Publishing
Descrizione fisica 1 online resource (360 p.)
Disciplina 616.07/54
Collana Advanced material series
Soggetto topico Diagnostic imaging
Nanotechnology - Health aspects
Nanomedicine
Cancer - Treatment
ISBN 1-118-99891-X
1-118-99892-8
1-118-99889-8
Classificazione TEC021000
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cover; Title Page; Copyright; Contents; Preface; Part 1: System Biology and Translational Medicine; 1 Aberrant Signaling Pathways; 1.1 Cancer; 1.2 Pathways Deregulated in Cancer: Introduction; 1.3 Introduction to Nanotechnology; 1.3.1 Overview of Clinical Nanotechnology; 1.3.2 Current Usage in Cancer Treatment; 1.4 Current Uses in Cancer Diagnostic; 1.4.1 The Phosphatidylinositol 3-Kinase-AKT Pathway; 1.4.2 The MAPK Pathway; 1.4.3 mTOR Pathway; 1.4.4 Receptor Tyrosine Kinase; Acknowledgment; References; 2 Application of Nanoparticles in Cancer Treatment; 2.1 Introduction; 2.1.1 Nanotechnology
2.1.2 Nanobiotechnology2.1.3 Nanotechnology in Medicine; 2.1.4 Cancer and Nano in Medicine; 2.2 Nanoparticles in Cancer Treatment; 2.3 Nanoparticle Platforms as Drug Delivery Systems for Cancer Therapy; 2.3.1 Lipid-based Nanoparticle Platforms; 2.3.2 Polymer-based Nanoparticle Platforms; 2.3.3 Protein-based Nanoparticle Platforms; 2.3.4 Inorganic Nanoparticle Platforms; 2.4 Theranostic Nanomedicine; 2.4.1 Theranostic Nanomedicine for Cancer Therapy; 2.5 Selective Drug Delivery and Encapsulation for Chemotherapy; 2.6 Stimuli-Sensitive Nanopreparations; 2.7 Multifunctional Nanopreparations
2.8 Cancer Nanotechnology: Future and ChallengesReferences; 3 Biomacromolecule-Gated Mesoporous Silica Drug Delivery Systems for Stimuli-Responsive Controlled Release; 3.1 Introduction; 3.2 Protein-Gated MSN Drug Delivery Systems; 3.2.1 Ligand-Binding Protein-Gated MSN Systems; 3.2.2 Metal-Chelating Protein-Gated MSN Systems; 3.3 DNA-Gated MSN Drug Delivery Systems; 3.3.1 Single-Stranded DNA-Gated MSN Systems; 3.3.2 Double-Stranded DNA-Gated MSN Systems; 3.3.3 Hairpin or Quadruplex DNA-Gated MSN Systems; 3.3.4 Native DNA-Gated MSN Systems
3.3.5 Near-Infrared Light-Triggered DNA-Gated MSN Systems3.4 Conclusions and Perspectives; Acknowledgments; References; 4 Construction of Functional DNA Nanostructures for Theranostic Applications; 4.1 The Progress of Structural DNA Nanotechnology; 4.2 DNA Nanostructures for Diagnostics; 4.3 DNA Nanostructures for Diagnostics on the Interface; 4.4 Diagnostic in Homogeneous Solution; 4.4.1 Spherical Nucleic Acids (SNA) Probes for Detections in Solution; 4.4.2 Nanochips in Solution; 4.4.3 Intracellular/In Vivo Diagnosis; 4.5 DNA Nanostructures for Therapeutics
4.5.1 Delivery of Small-Molecular Drugs4.5.2 Delivery of CpG DNAs; 4.5.3 RNA Interference (RNAi); 4.5.4 Delivery of Proteins; 4.6 Integration of Diagnosis and Therapy: Smart DNA Theranostic Nanodevices; 4.7 Targeted Delivery; 4.8 Controlled/Triggered Release; 4.9 Summary and Perspectives; 4.9.1 The Bioeffects of DNA Nanostructures; 4.9.2 Purity and Yield; 4.9.3 Dynamic Structures for Theranostic; References; Part 2: Imaging and Therapeutics; 5 Dimercaptosuccinic Acid-Coated Magnetic Nanoparticles as a Localized Delivery System in Cancer Immunotherapy; 5.1 Introduction
5.1.1 Nanoparticle-based Drug Delivery Systems
Record Nr. UNINA-9910131511603321
Salem, Massachusetts : , : Scrivener Publishing
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Advanced theranostic materials / / edited by Ashutosh Tiwari, Hirak K. Patra and Jeong-Woo Choi
Advanced theranostic materials / / edited by Ashutosh Tiwari, Hirak K. Patra and Jeong-Woo Choi
Pubbl/distr/stampa Salem, Massachusetts : , : Scrivener Publishing
Descrizione fisica 1 online resource (360 p.)
Disciplina 616.07/54
Collana Advanced material series
Soggetto topico Diagnostic imaging
Nanotechnology - Health aspects
Nanomedicine
Cancer - Treatment
ISBN 1-118-99891-X
1-118-99892-8
1-118-99889-8
Classificazione TEC021000
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cover; Title Page; Copyright; Contents; Preface; Part 1: System Biology and Translational Medicine; 1 Aberrant Signaling Pathways; 1.1 Cancer; 1.2 Pathways Deregulated in Cancer: Introduction; 1.3 Introduction to Nanotechnology; 1.3.1 Overview of Clinical Nanotechnology; 1.3.2 Current Usage in Cancer Treatment; 1.4 Current Uses in Cancer Diagnostic; 1.4.1 The Phosphatidylinositol 3-Kinase-AKT Pathway; 1.4.2 The MAPK Pathway; 1.4.3 mTOR Pathway; 1.4.4 Receptor Tyrosine Kinase; Acknowledgment; References; 2 Application of Nanoparticles in Cancer Treatment; 2.1 Introduction; 2.1.1 Nanotechnology
2.1.2 Nanobiotechnology2.1.3 Nanotechnology in Medicine; 2.1.4 Cancer and Nano in Medicine; 2.2 Nanoparticles in Cancer Treatment; 2.3 Nanoparticle Platforms as Drug Delivery Systems for Cancer Therapy; 2.3.1 Lipid-based Nanoparticle Platforms; 2.3.2 Polymer-based Nanoparticle Platforms; 2.3.3 Protein-based Nanoparticle Platforms; 2.3.4 Inorganic Nanoparticle Platforms; 2.4 Theranostic Nanomedicine; 2.4.1 Theranostic Nanomedicine for Cancer Therapy; 2.5 Selective Drug Delivery and Encapsulation for Chemotherapy; 2.6 Stimuli-Sensitive Nanopreparations; 2.7 Multifunctional Nanopreparations
2.8 Cancer Nanotechnology: Future and ChallengesReferences; 3 Biomacromolecule-Gated Mesoporous Silica Drug Delivery Systems for Stimuli-Responsive Controlled Release; 3.1 Introduction; 3.2 Protein-Gated MSN Drug Delivery Systems; 3.2.1 Ligand-Binding Protein-Gated MSN Systems; 3.2.2 Metal-Chelating Protein-Gated MSN Systems; 3.3 DNA-Gated MSN Drug Delivery Systems; 3.3.1 Single-Stranded DNA-Gated MSN Systems; 3.3.2 Double-Stranded DNA-Gated MSN Systems; 3.3.3 Hairpin or Quadruplex DNA-Gated MSN Systems; 3.3.4 Native DNA-Gated MSN Systems
3.3.5 Near-Infrared Light-Triggered DNA-Gated MSN Systems3.4 Conclusions and Perspectives; Acknowledgments; References; 4 Construction of Functional DNA Nanostructures for Theranostic Applications; 4.1 The Progress of Structural DNA Nanotechnology; 4.2 DNA Nanostructures for Diagnostics; 4.3 DNA Nanostructures for Diagnostics on the Interface; 4.4 Diagnostic in Homogeneous Solution; 4.4.1 Spherical Nucleic Acids (SNA) Probes for Detections in Solution; 4.4.2 Nanochips in Solution; 4.4.3 Intracellular/In Vivo Diagnosis; 4.5 DNA Nanostructures for Therapeutics
4.5.1 Delivery of Small-Molecular Drugs4.5.2 Delivery of CpG DNAs; 4.5.3 RNA Interference (RNAi); 4.5.4 Delivery of Proteins; 4.6 Integration of Diagnosis and Therapy: Smart DNA Theranostic Nanodevices; 4.7 Targeted Delivery; 4.8 Controlled/Triggered Release; 4.9 Summary and Perspectives; 4.9.1 The Bioeffects of DNA Nanostructures; 4.9.2 Purity and Yield; 4.9.3 Dynamic Structures for Theranostic; References; Part 2: Imaging and Therapeutics; 5 Dimercaptosuccinic Acid-Coated Magnetic Nanoparticles as a Localized Delivery System in Cancer Immunotherapy; 5.1 Introduction
5.1.1 Nanoparticle-based Drug Delivery Systems
Record Nr. UNINA-9910820125903321
Salem, Massachusetts : , : Scrivener Publishing
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui